US Dalteparin Sodium Market Size, Share and Forecast 2026-2034
The US dalteparin sodium market is driven by the growing prevalence of cardiovascular diseases, deep vein thrombosis (DVT), and pulmonary embolism, along with the increasing number of surgical procedures requiring anticoagulant therapy. Strong healthcare infrastructure, well-established clinical guidelines, and widespread adoption of low molecular weight heparins continue to support steady...
0 Commentarii
0 Distribuiri